Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock

Overview of attention for article published in Journal of Cardiac Failure, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 20 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 22 X posts from 20 X users, with an upper bound of 86,556 followers.

RT @SarasVallabhMD: Do we quantify our vasoactive medications appropriately in #CardiogenicShock? Read our work from the #CSWG published to…

Far too often, sequential addition of vasoactive medications is considered "less morbid" than MCS. Very important work by @SarasVallabhMD and #CSWG colleagues shows that it may not be all that "benign" after all! @NavinKapur4 @manreetkanwar @JCardFail …

RT @SarasVallabhMD: Do we quantify our vasoactive medications appropriately in #CardiogenicShock? Read our work from the #CSWG published to…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 18 additional X posts.